Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders

Published:2012-05-22 Issue:7 Volume:21 Page:921-947
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Robak Tadeusz¹²³,Robak Ewa⁴

Affiliation:

1. Medical University of Lodz, Department of Hematology, Lodz, Poland

2. Copernicus Memorial Hospital, Lodz, Poland

3. Medical University of Lodz, Copernicus Memorial Hospital, Department of Hematology, 93-510 Lodz, Ul. Ciolkowskiego 2, Poland ; ;

4. Medical University of Lodz, Department of Dermatology, Lodz, Poland

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.685650

Reference144 articles.

1. Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases

2. Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomas

3. Expression of Bruton's tyrosine kinase protein within the B cell lineage

4. Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity

5. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast cell stabilizers: from pathogenic roles to targeting therapies;Frontiers in Immunology;2024-08-01

2. Lomitapide repurposing for treatment of malignancies: A promising direction;Heliyon;2024-06

3. Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK);Bioorganic & Medicinal Chemistry;2023-12

4. Discovery of promising B lymphocyte kinase inhibitors using structure-guided virtual screening;Journal of Biomolecular Structure and Dynamics;2023-09-08

5. Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib;British Journal of Haematology;2022-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3